SomnoMed Limited (FRA:RJV)

Market Cap	97.14M
Revenue (ttm)	62.24M
Net Income (ttm)	-1.93M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	59.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,392
Average Volume	n/a
Open	0.4280
Previous Close	0.4300
Day's Range	0.4280 - 0.4280
52-Week Range	0.1490 - 0.5000
Beta	n/a
RSI	50.86
Earnings Date	Nov 28, 2025

About SomnoMed

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper te...

• Industry: Dental Equipment and Supplies
• Founded: 1987
• Employees: 300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RJV

Financial Performance

In 2025, SomnoMed's revenue was 111.49 million, an increase of 21.65% compared to the previous year's 91.65 million. Losses were -3.46 million, -71.77% less than in 2024.

Financial numbers in AUD